Wow.

So I found this quite remarkable.

And there, there are particular strains, uh, which have, um, been very helpful, um, and have been adopted in many neonatal intensive care units around the world, and it's led to great improvements.

And these are the, um, the m16V.

So we talked a bit about trademarks, so that's a trademark of a Bifidum brevis, uh, organism that's, um, trademark's owned by Morinaga, which is a, a Japanese, uh, probiotic company.

And the other one that they use was the m63 and the, the Bb 536.

Um, so that's a very targeted approach to, um, treatment.

Yeah, perfect.